BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28378067)

  • 1. Bone marrow myeloid cells in regulation of multiple myeloma progression.
    Herlihy SE; Lin C; Nefedova Y
    Cancer Immunol Immunother; 2017 Aug; 66(8):1007-1014. PubMed ID: 28378067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.
    Ramachandran IR; Condamine T; Lin C; Herlihy SE; Garfall A; Vogl DT; Gabrilovich DI; Nefedova Y
    Cancer Lett; 2016 Feb; 371(1):117-24. PubMed ID: 26639197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
    Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
    Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.
    Asimakopoulos F; Hope C; Johnson MG; Pagenkopf A; Gromek K; Nagel B
    J Leukoc Biol; 2017 Aug; 102(2):265-275. PubMed ID: 28254840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
    Bailur JK; McCachren SS; Doxie DB; Shrestha M; Pendleton K; Nooka AK; Neparidze N; Parker TL; Bar N; Kaufman JL; Hofmeister CC; Boise LH; Lonial S; Kemp ML; Dhodapkar KM; Dhodapkar MV
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.
    Yen CH; Hsiao HH
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30405034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
    Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
    Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma.
    de Jong MME; Fokkema C; Papazian N; Czeti Á; Appelman MK; Vermeulen M; van Heusden T; Hoogenboezem RM; van Beek G; Tahri S; Sanders MA; van de Woestijne PC; Gay F; Moreau P; Büttner-Herold M; Bruns H; van Duin M; Broijl A; Sonneveld P; Cupedo T
    Nat Immunol; 2024 May; 25(5):820-833. PubMed ID: 38600356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
    Nair JR; Carlson LM; Koorella C; Rozanski CH; Byrne GE; Bergsagel PL; Shaughnessy JP; Boise LH; Chanan-Khan A; Lee KP
    J Immunol; 2011 Aug; 187(3):1243-53. PubMed ID: 21715687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
    Shay G; Hazlehurst L; Lynch CC
    J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity.
    Petersson J; Askman S; Pettersson Å; Wichert S; Hellmark T; Johansson ÅCM; Hansson M
    J Immunol Res; 2021; 2021():6344344. PubMed ID: 34414242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
    Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
    Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma.
    Williams CMD; Noll JE; Bradey AL; Duggan J; Wilczek VJ; Masavuli MG; Grubor-Bauk B; Panagopoulos RA; Hewett DR; Mrozik KM; Zannettino ACW; Vandyke K; Panagopoulos V
    Br J Haematol; 2023 Nov; 203(4):614-624. PubMed ID: 37699574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
    Mougiakakos D; Bach C; Böttcher M; Beier F; Röhner L; Stoll A; Rehli M; Gebhard C; Lischer C; Eberhardt M; Vera J; Büttner-Herold M; Bitterer K; Balzer H; Leffler M; Jitschin S; Hundemer M; Awwad MHS; Busch M; Stenger S; Völkl S; Schütz C; Krönke J; Mackensen A; Bruns H
    Cancer Immunol Res; 2021 Mar; 9(3):265-278. PubMed ID: 33563611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow.
    Matthes T; Manfroi B; Zeller A; Dunand-Sauthier I; Bogen B; Huard B
    Leukemia; 2015 Sep; 29(9):1882-90. PubMed ID: 26159051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological dysregulation in multiple myeloma microenvironment.
    Romano A; Conticello C; Cavalli M; Vetro C; La Fauci A; Parrinello NL; Di Raimondo F
    Biomed Res Int; 2014; 2014():198539. PubMed ID: 25013764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.
    Ramachandran IR; Martner A; Pisklakova A; Condamine T; Chase T; Vogl T; Roth J; Gabrilovich D; Nefedova Y
    J Immunol; 2013 Apr; 190(7):3815-23. PubMed ID: 23460744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
    Foglietta M; Castella B; Mariani S; Coscia M; Godio L; Ferracini R; Ruggeri M; Muccio V; Omedé P; Palumbo A; Boccadoro M; Massaia M
    Haematologica; 2014 Oct; 99(10):1605-10. PubMed ID: 24972771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
    Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
    Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.